Phase 3 Study of Androgen Deprivation Therapy (ADT) with Enzalutamide (ENZA) or Placebo (PBO) in Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): The Arches Trial
Publication
, Conference
Horvath, L; Armstrong, AJ; Szmulewitz, R; Petrylak, D; Villers, A; Azad, A; Alcaraz, A; Alekseev, B; Iguchi, T; Shore, ND; Rosbrook, B ...
Published in: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
July 1, 2019
Duke Scholars
Published In
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
EISSN
1743-7563
ISSN
1743-7555
Publication Date
July 1, 2019
Volume
15
Start / End Page
32 / 33
Publisher
WILEY
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Horvath, L., Armstrong, A. J., Szmulewitz, R., Petrylak, D., Villers, A., Azad, A., … Stenzl, A. (2019). Phase 3 Study of Androgen Deprivation Therapy (ADT) with Enzalutamide (ENZA) or Placebo (PBO) in Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): The Arches Trial. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (Vol. 15, pp. 32–33). WILEY.
Horvath, Lisa, Andrew J. Armstrong, Russell Szmulewitz, Daniel Petrylak, Arnauld Villers, Arun Azad, Antonio Alcaraz, et al. “Phase 3 Study of Androgen Deprivation Therapy (ADT) with Enzalutamide (ENZA) or Placebo (PBO) in Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): The Arches Trial.” In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 15:32–33. WILEY, 2019.
Horvath L, Armstrong AJ, Szmulewitz R, Petrylak D, Villers A, Azad A, et al. Phase 3 Study of Androgen Deprivation Therapy (ADT) with Enzalutamide (ENZA) or Placebo (PBO) in Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): The Arches Trial. In: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY; 2019. p. 32–3.
Horvath, Lisa, et al. “Phase 3 Study of Androgen Deprivation Therapy (ADT) with Enzalutamide (ENZA) or Placebo (PBO) in Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): The Arches Trial.” ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol. 15, WILEY, 2019, pp. 32–33.
Horvath L, Armstrong AJ, Szmulewitz R, Petrylak D, Villers A, Azad A, Alcaraz A, Alekseev B, Iguchi T, Shore ND, Rosbrook B, Sugg J, Baron B, Chen L, Stenzl A. Phase 3 Study of Androgen Deprivation Therapy (ADT) with Enzalutamide (ENZA) or Placebo (PBO) in Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): The Arches Trial. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY; 2019. p. 32–33.
Published In
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
EISSN
1743-7563
ISSN
1743-7555
Publication Date
July 1, 2019
Volume
15
Start / End Page
32 / 33
Publisher
WILEY
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis